Increased ascertainment of those at risk, with confirmation of a diagnosis of CHD, will affect prevalence proportion.
Higher cluster prevalence may reflect one or more of higher population disease prevalence; opportunity to improve delivery of behaviour change interventions; opportunity to improve identification and/ or management of clinical risk factors; access to health care; or the effectiveness of case finding.